Journal of Developmental Medicine(Electronic Version) 2026, Vol. 14 Issue (5): 406-411,419 DOI: 10.3969/j.issn.2095-5340.2026.05.006 |
|
|
|
|
|
|
Exploring the causal relationship between gut microbiota and Tourette syndrome based on Mendelian randomization
|
| Hu Zhengyun, Zhang Tao, Hong Xianhui, et al
|
1.Department of Pediatrics, Songjiang Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 201600, China; 2. Department of Pediatrics, The First Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing, Jiangsu 210029, China
|
|
|
|
|
Abstract
Objective To investigate the causal relationship between gut microbiota and Tourette syndrome (TS) using a Mendelian randomization (MR) approach. Methods Genetic data of human gut microbiota were obtained from the MiBioGen consortium, identifying 196 microbial taxa (including 9 phyla, 16 classes, 20 orders, 32 families and 119 genera) as exposure variables to construct robust MR instrumental variables. Genome-wide association study (GWAS) data for TS were incorporated, the causal relationships between gut microbiota and TS were comprehensively assessed using inverse-variance weighted (IVW), MR-Egger regression, weighted median estimator (WME), weighted mode (WM), and simple mode (SM) methods. Statistical robustness was evaluated through Cochran's Q test for heterogeneity, MR-Egger regression test for horizontal pleiotropy, and MR-PRESSO for outlier detection and removal. Results Among 112 single nucleotide polymorphisms (SNPs) selected as instrumental variables, the abundance of the Bifidobacterium was significantly negatively correlated with TS (OR=0.980, 95% CI : 0.975–0.985, P=1.141×10-14). Conclusions There is a negative causal effect between the abundance of the Bifidobacterium and TS. This study validates that Bifidobacterium may participate in the pathogenesis and progression of TS via the gut-brain axis, immunomodulatory mechanisms, and neurotransmitter metabolism providing novel genetic-epidemiological evidence for subsequent research on gut microbiota intervention and probiotic related studies.
|
|
Received: 19 February 2025
Published: 30 September 2026
|
|
|
|
|
|